| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8952406 | Brachytherapy | 2018 | 5 Pages |
Abstract
Biochemical recurrence after attaining a PSA nadir <0.2Â ng/mL is rare and more frequent in patients with intermediate risk cancer and older patients. These patients can benefit from a prolonged followup with specialized physicians.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel Taussky, Carole Lambert, Nissan Meissner, Jean-Paul Bahary, Guila Delouya,